Numerous studies have shown that elevated serum S100B levels are associated with increased aggressiveness and decreased survival in melanoma, suggesting that S100B can be used as a prognostic marker32–35, S100B is also valuable for monitoring patients during treatment, with increased levels associated with disease progression and decreased levels associated with disease regression34,36. The gene discussed is S100B; the disease is melanoma.